Research Use Only - Not for human consumption. 18+ only.

Selank vs Dihexa

Evidence-based comparison · Updated 2026

Summary

Selank is better suited for individuals seeking anxiety reduction alongside cognitive enhancement, with a stronger evidence base and broader regulatory access. Dihexa targets neuroplasticity and BDNF signaling at a more structural level, making it relevant for neurodegeneration research contexts. Choose Selank for anxiety-driven cognitive impairment; consider Dihexa only within research settings focused on synaptic plasticity and memory consolidation.

Side-by-Side Comparison

SelankDihexa
EvidenceBGrade BSmaller human trials, observational studies, or approved in 30+ countriesDGrade DTheoretical or in-vitro only; no meaningful independent human evidence
RegulatoryCompoundableCompoundableLegal to compound in the US; approved in other jurisdictions or has historical approvalResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only
Benefits
  • +Reduces anxiety and stress responses
  • +Enhances memory and cognitive function
  • +Improves mood and emotional resilience
  • +Supports immune system modulation
  • +Increases mental clarity and focus
  • +Enhances BDNF signaling in the brain
  • +Improves synaptic plasticity and density
  • +Supports cognitive function and memory
  • +Promotes neuronal survival and growth
  • +May enhance learning capacity
Dosage250-500 mcg — 1-2x daily50-300 mcg — 1-2x daily
RouteSubcutaneousSubcutaneous
CategoryCognitive EnhancementCognitive Enhancement

Full research page

Selank →

Full research page

Dihexa →

Which Should You Choose?

Selank primarily modulates neurotransmitter systems including GABA and dopamine to reduce anxiety and sharpen cognition, while Dihexa operates by amplifying endogenous BDNF signaling to enhance synaptic density and neuroplasticity at a structural level. These represent distinct intervention points: acute neurotransmitter balance versus longer-term synaptic remodeling.

Choose Selank when:

  • +You are primarily managing anxiety or stress-related cognitive impairment and need a peptide with a stronger clinical evidence base.
  • +You require a compoundable peptide with broader regulatory access rather than a research-only compound.
  • +You are looking for immunomodulatory effects alongside anxiolysis and cognitive support within a single agent.

Choose Dihexa when:

  • +Your research focus is on BDNF-mediated neuroplasticity, synaptic density, or long-term potentiation mechanisms.
  • +You are investigating neuroprotective interventions against age-related or pathological neurodegeneration in a controlled research context.
  • +You need a compound specifically targeting TrkB receptor signaling to study learning capacity and neuronal survival.

Stacking Selank and Dihexa is not a widely documented practice in published research, but the mechanistic complementarity between Selank's neurotransmitter modulation and Dihexa's structural neuroplasticity effects makes this combination a theoretical area of interest for researchers studying multi-target cognitive support.

Frequently Asked Questions

Do Selank and Dihexa work through overlapping mechanisms, or are they fully distinct?⌄
The two peptides have minimal mechanistic overlap. Selank modulates GABA and dopamine pathways to produce anxiolytic and acute cognitive effects, while Dihexa potentiates BDNF signaling through TrkB receptor activation to drive longer-term synaptic remodeling. Both support neuroprotection and cognitive function, but they do so through separate and largely non-competing pathways, which is why researchers sometimes consider them complementary rather than redundant.
Which peptide would produce noticeable cognitive effects more quickly, Selank or Dihexa?⌄
Selank is generally associated with more immediate effects due to its direct modulation of GABA and dopamine neurotransmitter systems, with research subjects reporting reduced anxiety and improved mental clarity within the same administration window. Dihexa's mechanism involves structural changes in synaptic density and neurotrophin expression, which are processes that typically unfold over longer timeframes. For near-term cognitive outcomes, Selank's evidence profile is more consistent with rapid onset.
Is combining Selank and Dihexa in a research stack scientifically justified?⌄
There is currently no published clinical or preclinical research specifically evaluating the co-administration of Selank and Dihexa. The theoretical rationale for combining them rests on their distinct mechanisms: Selank addressing neurotransmitter-level anxiety and cognition while Dihexa supports synaptic architecture through BDNF potentiation. Whether these effects are additive, synergistic, or neutral in combination remains an open question that would require dedicated study to evaluate responsibly.
How do the evidence grades of Selank and Dihexa affect the decision between them?⌄
Selank carries a grade B evidence rating, reflecting a more substantial body of peer-reviewed research supporting its anxiolytic, immunomodulatory, and cognitive effects in humans and animals. Dihexa is rated grade D, meaning its findings are largely limited to preclinical or early-stage research with limited human data. This gap in evidence maturity is a practical consideration: Selank has a more defined safety and efficacy profile, while Dihexa remains in earlier stages of characterization and is restricted to research use only.

Not sure which fits your research goals?

Use the Goal Finder

Answer 3 questions and get a personalised peptide recommendation ranked by evidence grade.

Find My Peptide →

More Comparisons

bpc 157 vs tb 500mots c vs semaglutidedsip vs melanotan iiretatrutide vs tirzepatidecjc 1295 vs ipamorelin